Strategies for Processing Drug Information Documents and Developing Drug Information Files

  • Charles F. Curran
  • Murali N. Sundar


The components of document processing and filing are enumerated and described. Desirable attributes of a filing system are listed. Various filing procedures and filing strategies are discussed in terms of their usefulness to a pharmaceutical company drug information department. Because the hierarchical filing system appears to offer maximum benefit to drug information departments, this system is described in greater detail. Suggestions are provided to maximize efficiency in processing new documents and their subsequent retrieval through coherent and uniform filing design. Suggested strategies are outlined to identify and acquire new materials in order to keep drug information department files current. Measures are suggested for locating misplaced documents.

Key Words

Drug information Document processing Filing 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    De Vries MA. The Office Sourcebook. Englewood Cliffs, NJ: Prentice-Hall: 1989:9–21.Google Scholar
  2. 2.
    Goodman DG. Fosegan JS, Bassett ED. Business Records Control. 6th Ed. Cincinnati, OH: South-Western Publishing Co.; 1985:115–118.Google Scholar
  3. 3.
    Soukhanov AH, ed. Webster’s Medical Office Handbook. Springfield, MA: G. & C. Merriam Co.; 1979: 145–186.Google Scholar
  4. 4.
    Chapter 2 Records Management—General Information. Filing Systems and equipment. In: Oregon State University Administrative Policies and Procedures. Archives & Records Management Handbook, Accessed September 5, 2001.
  5. 5.
    Copyright Clearance Center, Inc. Transactional Reporting Service. TRScorporate.asp. Accessed September 5, 2001.
  6. 6.
    Title 17 United States Code. Chapter 5—Copyright Infringement and Remedies. Sec. 504. Remedies for infringement: Damages and profits. Washington, DC: US Government Printing Office; 2000.Google Scholar

Copyright information

© Drug Information Association, Inc 2002

Authors and Affiliations

  • Charles F. Curran
    • 1
  • Murali N. Sundar
    • 2
  1. 1.St. LouisUSA
  2. 2.Professional Affairs, Forest Pharmaceuticals, Inc.St. LouisUSA

Personalised recommendations